NCT05157126View on ClinicalTrials.gov

Gentamicin Open Tibia Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

890

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2029

Conditions
Fracture Open Tibia
Interventions
DRUG

Gentamicin

Liquid gentamicin administered at the open fracture site

DRUG

normal Saline

Normal saline administered at the open fracture site

Trial Locations (1)

Unknown

RECRUITING

Muhimbili Orthopaedic Institute, Dar es Salaam

All Listed Sponsors
collaborator

Muhimbili Orthopaedic Institute

OTHER

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

Orthopedic Research and Education Foundation

OTHER

lead

University of California, San Francisco

OTHER